跳至主要内容
临床试验/NCT02970695
NCT02970695已完成不适用

Effectiveness of Auriculotherapy on Older People With Insomnia

The Hong Kong Polytechnic University2 个研究点 分布在 1 个国家目标入组 147 人开始时间: 2016年5月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
147
试验地点
2
主要终点
Pittsburgh Sleep Quality Index (PSQI)

研究概览

简要总结

Objective To determine the optimum treatment protocol of auriculotherapy (AT) on the improvement of sleep conditions and quality of life on the elders with insomnia.

Research hypothesis The use of combined LAT plus MAT is more effective than MAT/LAT alone on the improvement of sleep conditions and quality of life in the elderly with insomnia.

Design and subjects This is a 3-arm double-blinded randomised trial. Subjects aged ≥65 and exhibit poor sleep conditions are recruited.

Interventions Group 1: Subjects will receive a deactivated laser treatment followed by MAT. Group 2: Subjects will receive LAT and placebo MAT. Group 3: Subjects will receive a combined approach (LAT plus MAT).

The treatment will be delivered 3 times/week, with a 6-week treatment period, on seven specific auricular points.

Main outcome measures Sleep conditions and quality of life will be evaluated at baseline; end of 6-week treatment; and at 6-week, 12-week, and 6-month follow-up periods.

Data analysis Descriptive statistics, chi-square analysis, ANOVA, paired t-test, and mixed effect modeling will be conducted as appropriate.

Expected results This study would advance our knowledge the optimum treatment protocol of AT in the improvement of the sleep conditions of the elderly population.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Volunteers who are aged 65 or above
  • Report having difficulty falling or staying asleep, and/or frequent nocturnal awakenings
  • At least three nights per week, sleep disturbance has lasted for a minimum of six months
  • Their sleep is of poor quality as indicated by a PSQI score greater than five.

排除标准

  • profound physical illness, such as stroke
  • diagnosed with obstructive sleep apnoea
  • having a hearing aid or pacemaker in situ (to prevent the magnetic pellets from interfering with the devices)
  • receiving AT within the preceding 6 months,
  • suffering from aural injuries or infections, and
  • inability to understand instructions or give consent.

研究组 & 干预措施

Treatment arm 1

Active Comparator

To achieve a blinding and placebo effect of the subject, the laser device will be switched to "power off" mode (i.e. deactivated laser) for acupoint "stimulation" before the application of MAT. The subjects will be asked to wear a pair of laser protective goggles so as to "blind" them during treatment.

干预措施: magneto-auriculotherapy (MAT) (Device)

Treatment arm 2

Active Comparator

Subjects will receive LAT. A laser device (Pointer Pulse™) will be used in this study.

干预措施: Laser auriculotherapy (LAT) (Device)

Treatment arm 3

Experimental

Subjects will receive a combined approach that includes the use of LAT plus MAT. LAT will be administered prior to MAT application on the selected auricular points, and the procedures used will be similar to the procedures described for Group 1 and Group 2.

干预措施: magneto-auriculotherapy (MAT) (Device)

Treatment arm 3

Experimental

Subjects will receive a combined approach that includes the use of LAT plus MAT. LAT will be administered prior to MAT application on the selected auricular points, and the procedures used will be similar to the procedures described for Group 1 and Group 2.

干预措施: Laser auriculotherapy (LAT) (Device)

结局指标

主要结局

Pittsburgh Sleep Quality Index (PSQI)

时间窗: up to 6-month follow up

for collecting data related to the sleep patterns of the subjects. The total score ranges from 0 to 21, with a score greater than five indicating poor sleep quality. Chong and Cheung19 have validated the Cantonese-PSQI and have reported a high internal consistency of 0.75.

次要结局

  • Sleep latency(up to 6-month follow up)
  • Wake after sleep onset(up to 6-month follow up)
  • Total sleep time(up to 6-month follow up)
  • Sleep efficiency(up to 6-month follow up)
  • The Chinese (HK) specific SF-12 v2©(up to 6-month follow up)
  • Patient Health Questionnaire(up to 6-month follow up)
  • Insomnia Severity Index(up to 6-month follow up)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lorna Suen

Associate Professor

The Hong Kong Polytechnic University

研究点 (2)

Loading locations...

相似试验